Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projected to experience robust earnings growth, with GAAP earnings expected to reach $4.73 per diluted share in 2025 and increase further to $5.17 per diluted share in 2026, reflecting strong performance in the Human Nutrition and Health segment. The company reported $255.5 million in top-line revenue for the second quarter of 2025, surpassing estimates and demonstrating a slight improvement from both the previous quarter and the same period last year. Additionally, Balchem's financial outlook is reinforced by improving gross and net margins, potential for a debt-free status by the end of next year, and opportunities for accretive mergers and acquisitions due to its strong balance sheet.

Bears say

Balchem Corp has experienced a decline in its price-to-earnings (P/E) multiple from 39.6x to 37.9x, indicating a modest increase in its price target despite underlying revenue and earnings trends weakening within its peer group. The company faces several risks, including slower growth in its core businesses, inflationary pressures affecting its operations, and potential disruptions from regional conflicts, particularly impacting its European operations. Additionally, the Animal Nutrition and Health segment reported sales of $56.4 million, below the estimate of $60 million, further highlighting challenges in achieving revenue targets across its various segments.

Balchem (BCPC) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Balchem (BCPC) has a Strong Buy consensus rating as of Oct 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $190, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $190, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.